Pfizer vaccines for children aged 5 to 11 moves one step closer in US
Pfizer vaccines for children aged 5 to 11 moves one step closer in US
FDA advisers back Pfizer’s COVID-19 vaccine for young kids, ages 5 to 11 (Pictures: Reuters/ Getty)
A panel of US health advisors have voted to authorize the use of Pfizer-BioNTech’s Covid-19 vaccine for young children.
In an unanimous vote to OK the Pfizer vaccine for children ages 5-11, a Food and Drug Administration advisory panel said the data shows that the vaccine’s benefits in preventing…
Discover more from USNewsRank
Subscribe to get the latest posts sent to your email.